Speciality bio-pharmaceutical company Shire has announced the retirement of Non-Executive Chairman Matthew Emmens, who joined the company as Chief Executive in 2003 and became Chairman five years later.

He will be succeeded by Susan Kilsby, Chairman of Shire's Audit, Compliance & Risk Committee, at the group's annual general meeting on April 29th.

Emmens said: "I have thoroughly enjoyed my 10-plus years with Shire. The company has developed so much during this time and it continues to thrive and grow. Having worked with Susan [Kilsby] on the board over the past few years I believe she is the ideal Chairman for Shire as the company embarks on another new era of growth."

Kilsby joined the board in a non-executive role in 2011, before becoming committee Chairman in May lst year.

Deputy Chairman David Kappler added that he believed Kilsby would make an "excellent" Chairman.

NR

Related share prices
() share price
() share price
() share price
() share price
D (D) share price
S (S) share price
() share price
() share price